We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
According to GlobalData’s report, ‘Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027, Japan contributed US$1.9bn to the global RA market sales in 2017, representing 8.0 per cent of total sales across the 8MM*.